AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY
Authors: GOEDHALS L HERON JF KLEISBAUER JP PAGANI O SESSA C GIGER K CAVALLI F LUDWIG C AAPRO M BLEIBERG H DEWASH G DICATO M TAGNON A VANSTRAELEN D VINDEVOGHEL A ABRATT R FALKSON G BARLEY V CARMICHAEL J COLEMAN R DAVIDSON N GRIEVE R HARPER P ROBERTS J RUSTIN G NAMAN H SCHNEIDER M NOBLE A NETTER P CUPISSOL D BALMES P CALS L KHAYAT D CATIMEL G DUTIN JP BOUFETTE P ADENIS L MISSET J COLLERY P NOUVET G CHAVAILLON JM BLANCHON F POIRIER R ARNAUD A LECAER H CARLES P MUIR J BONNAUD F MARQUESTE L CLAVIER J GUERIN J TAYTARD A KEIZER H NORTIER J SLEE P WILS J RODENBURG C BURGHOUTS J DEWIT R GARCIAGIRON C JIMENEZLACAVE A CRUZHERNANDEZ J MASSUTISUREDA B HANS K FUCHS R KRIEGMAIR M SCHULLER J LAHOUSEN M PANNUTI F MONFARDINI S NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
EASTERN-COOPERATIVE-ONCOLOGY-GROUP RANDOMIZED TRIALS OF OBSERVATION VERSUS MAINTENANCE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER IN COMPLETE REMISSION FOLLOWING INDUCTION TREATMENT
Authors: FALKSON G GELMAN RS PANDYA KJ OSBORNE CK TORMEY D CUMMINGS FJ SLEDGE GW ABELOFF MD
Citation: G. Falkson et al., EASTERN-COOPERATIVE-ONCOLOGY-GROUP RANDOMIZED TRIALS OF OBSERVATION VERSUS MAINTENANCE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER IN COMPLETE REMISSION FOLLOWING INDUCTION TREATMENT, Journal of clinical oncology, 16(5), 1998, pp. 1669-1676
LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE
Authors: DOMBERNOWSKY P SMITH I FALKSON G LEONARD R PANASCI L BELLMUNT J BEZWODA W GARDIN G GUDGEON A MORGAN M FORNASIERO A HOFFMANN W MICHEL J HATSCHEK T TJABBES T CHAUDRI HA HORNBERGER U TRUNET PF
Citation: P. Dombernowsky et al., LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE, Journal of clinical oncology, 16(2), 1998, pp. 453-461
SURVIVAL ADVANTAGE OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - 10-YEAR ANALYSIS - AN INTERGROUP STUDY
Authors: MANSOUR EG GRAY R SHATILA AH TORMEY DC COOPER MR OSBORNE CK FALKSON G
Citation: Eg. Mansour et al., SURVIVAL ADVANTAGE OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - 10-YEAR ANALYSIS - AN INTERGROUP STUDY, Journal of clinical oncology, 16(11), 1998, pp. 3486-3492
A RANDOMIZED STUDY OF RADIOTHERAPY ALONE VERSUS RADIOTHERAPY PLUS 5-FLUOROURACIL AND PLATINUM IN PATIENTS WITH INOPERABLE, LOCALLY ADVANCEDSQUAMOUS CANCER OF THE ESOPHAGUS
Authors: SLABBER CF NEL JS SCHOEMAN L BURGER W FALKSON G FALKSON CI
Citation: Cf. Slabber et al., A RANDOMIZED STUDY OF RADIOTHERAPY ALONE VERSUS RADIOTHERAPY PLUS 5-FLUOROURACIL AND PLATINUM IN PATIENTS WITH INOPERABLE, LOCALLY ADVANCEDSQUAMOUS CANCER OF THE ESOPHAGUS, American journal of clinical oncology, 21(5), 1998, pp. 462-465
INDUCTION CHEMOTHERAPY OF DIBROMODULCITOL, ADRIAMYCIN(R), VINCRISTINE, TAMOXIFEN, AND HALOTESTIN(R) WITH METHOTREXATE IN METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E1181)
Authors: CHANG AY PUTT M PANDYA KJ HARRIS J GELMAN R TORMEY DC FALKSON G
Citation: Ay. Chang et al., INDUCTION CHEMOTHERAPY OF DIBROMODULCITOL, ADRIAMYCIN(R), VINCRISTINE, TAMOXIFEN, AND HALOTESTIN(R) WITH METHOTREXATE IN METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (E1181), American journal of clinical oncology, 21(1), 1998, pp. 99-104
FADROZOLE VERSUS MEGESTROL-ACETATE - A DOUBLE-BLIND RANDOMIZED TRIAL IN ADVANCED BREAST-CANCER
Authors: BEZWODA WR GUDGEON A FALKSON G JORDAAN JP GOEDHALS L
Citation: Wr. Bezwoda et al., FADROZOLE VERSUS MEGESTROL-ACETATE - A DOUBLE-BLIND RANDOMIZED TRIAL IN ADVANCED BREAST-CANCER, Oncology, 55(5), 1998, pp. 416-420
NEOADJUVANT CISPLATIN PLUS IFOSFAMIDE IN PATIENTS WITH STAGE IIB CERVICAL-CANCER - A SINGLE-CENTER PHASE-II STUDY
Authors: DEJONGE ETM FALKSON G BURGER W SCHOEMAN L LINDEQUE BG
Citation: Etm. Dejonge et al., NEOADJUVANT CISPLATIN PLUS IFOSFAMIDE IN PATIENTS WITH STAGE IIB CERVICAL-CANCER - A SINGLE-CENTER PHASE-II STUDY, International journal of gynecological cancer, 7(2), 1997, pp. 158-162
LOW SERUM TESTOSTERONE AND A YOUNGER AGE PREDICT FOR A POOR OUTCOME IN METASTATIC PROSTATE-CANCER
Authors: RIBEIRO M RUFF P FALKSON G
Citation: M. Ribeiro et al., LOW SERUM TESTOSTERONE AND A YOUNGER AGE PREDICT FOR A POOR OUTCOME IN METASTATIC PROSTATE-CANCER, American journal of clinical oncology, 20(6), 1997, pp. 605-608
THE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS
Authors: EEK R FALKSON G
Citation: R. Eek et G. Falkson, THE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS, Oncology, 54(6), 1997, pp. 441-458
THE ROLE OF RADIOTHERAPY IN THE MANAGEMENT OF OPERABLE LOCALLY ADVANCED BREAST-CARCINOMA - RESULTS OF A RANDOMIZED TRIAL BY THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
Authors: OLSON JE NEUBERG D PANDYA KJ RICHTER MP SOLIN LJ GILCHRIST KW TORMEY DC VEEDER M FALKSON G
Citation: Je. Olson et al., THE ROLE OF RADIOTHERAPY IN THE MANAGEMENT OF OPERABLE LOCALLY ADVANCED BREAST-CARCINOMA - RESULTS OF A RANDOMIZED TRIAL BY THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP, Cancer, 79(6), 1997, pp. 1138-1149
A PHASE-II TRIAL OF FLUDARABINE IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: HOCEPIED AMLJ FALKSON CI FALKSON G
Citation: Amlj. Hocepied et al., A PHASE-II TRIAL OF FLUDARABINE IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, South African medical journal, 86(5), 1996, pp. 549-550
13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER - A PHASE-II TRIAL
Authors: SLABBER CF FALKSON G BURGER W SCHOEMAN L
Citation: Cf. Slabber et al., 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER - A PHASE-II TRIAL, Investigational new drugs, 14(4), 1996, pp. 391-394
CISPLATIN VERSUS CISPLATIN PLUS D-TRP-6-LHRH IN THE TREATMENT OF OVARIAN-CANCER - A PILOT TRIAL TO INVESTIGATE THE EFFECT OF THE ADDITION OF A GNRH ANALOG TO CISPLATIN
Authors: FALKSON CI FALKSON HC FALKSON G
Citation: Ci. Falkson et al., CISPLATIN VERSUS CISPLATIN PLUS D-TRP-6-LHRH IN THE TREATMENT OF OVARIAN-CANCER - A PILOT TRIAL TO INVESTIGATE THE EFFECT OF THE ADDITION OF A GNRH ANALOG TO CISPLATIN, Oncology, 53(4), 1996, pp. 313-317
10-YEAR FOLLOW-UP-STUDY OF PREMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
Authors: FALKSON G HOLCROFT C GELMAN RS TORMEY DC WOLTER JM CUMMINGS FJ
Citation: G. Falkson et al., 10-YEAR FOLLOW-UP-STUDY OF PREMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(6), 1995, pp. 1453-1458
HEPATOCELLULAR-CARCINOMA - AN ECOG RANDOMIZED PHASE-II STUDY OF INTERFERON-BETA AND MENAGORIL
Authors: FALKSON G LIPSITZ S BORDEN E SIMSON I HALLER D
Citation: G. Falkson et al., HEPATOCELLULAR-CARCINOMA - AN ECOG RANDOMIZED PHASE-II STUDY OF INTERFERON-BETA AND MENAGORIL, American journal of clinical oncology, 18(4), 1995, pp. 287-292
ANTIEMETIC TREATMENT WITH ORAL GRANISETRON IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY - A DOSE-RANGING STUDY
Authors: BLEIBERG HH SPIELMANN M FALKSON G ROMAIN D
Citation: Hh. Bleiberg et al., ANTIEMETIC TREATMENT WITH ORAL GRANISETRON IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY - A DOSE-RANGING STUDY, Clinical therapeutics, 17(1), 1995, pp. 38-51
A PHASE-II TRIAL OF VINDESINE IN HEPATOCELLULAR CANCER
Authors: FALKSON G BURGER W
Citation: G. Falkson et W. Burger, A PHASE-II TRIAL OF VINDESINE IN HEPATOCELLULAR CANCER, Oncology, 52(1), 1995, pp. 86-87
A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: GOEDHALS L JORDAAN JP KAYE SB ARMAND JP VEENHOF CHN FALKSON G SOUKOP M SCHNEIDER M OBERLING F BUI BN ROCHE H ADENIS L CATY A BLIJHAM GH DEWEWEIRE A COIFFIER B SOTTO JJ VANHEUKELOM LS TAGNON A SLEE PHTJ KROEKS MVAM RAVEZ P CUPISSOL D KEIZER HJ BRUNNER K CALVERT AH YERNAULT JC LIBERT P BROHEE D
Citation: L. Goedhals et al., A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Supportive care in cancer, 2(3), 1994, pp. 177-183
EFFICACY AND SAFETY PROFILE OF GEMCITABINE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
Authors: ABRATT RP BEZWODA WR FALKSON G GOEDHALS L HACKING D RUGG TA
Citation: Rp. Abratt et al., EFFICACY AND SAFETY PROFILE OF GEMCITABINE IN NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 12(8), 1994, pp. 1535-1540
MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID-LEUKEMIA SECONDARY TO MITOLACTOL TREATMENT IN PATIENTS WITH BREAST-CANCER
Authors: BENNETT JM TROXEL AB GELMAN R FALKSON G DREICER R TORMEY DC RUSHING D COCCIAPORTUGAL MD
Citation: Jm. Bennett et al., MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID-LEUKEMIA SECONDARY TO MITOLACTOL TREATMENT IN PATIENTS WITH BREAST-CANCER, Journal of clinical oncology, 12(4), 1994, pp. 874-875
REINDUCTION WITH THE SAME CYTOSTATIC TREATMENT IN PATIENTS WITH METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
Authors: FALKSON G GELMAN R GLICK J FALKSON CI HARRIS J
Citation: G. Falkson et al., REINDUCTION WITH THE SAME CYTOSTATIC TREATMENT IN PATIENTS WITH METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 12(1), 1994, pp. 45-49
PHASE-II TRIAL OF FOTEMUSTINE IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
Authors: FALKSON CI FALKSON G FALKSON HC
Citation: Ci. Falkson et al., PHASE-II TRIAL OF FOTEMUSTINE IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA, Investigational new drugs, 12(3), 1994, pp. 251-254
FIVB PLUS GM-CSF IN METASTATIC COLORECTAL-CANCER
Authors: FALKSON CI FALKSON G FALKSON HC UYS A KERENROSENBERG S
Citation: Ci. Falkson et al., FIVB PLUS GM-CSF IN METASTATIC COLORECTAL-CANCER, Investigational new drugs, 12(1), 1994, pp. 49-52
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CANCER-RELATED ANEMIA
Authors: FALKSON CI KERENROSENBERG S UYS A FALKSON G STEVENS K VERMAAK WJH
Citation: Ci. Falkson et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF CANCER-RELATED ANEMIA, Oncology, 51(6), 1994, pp. 497-501
Risultati: 1-25 | 26-31